Cannabis Update - On Demand

About the event

This course is provided by College Education and Training, a business unit of Pharmaceutical Society of New Zealand Inc.

Presented by: Elizabeth Plant & Chris James

Elizabeth Plant is Chief Medical Officer of EQALIS Research Ltd, a new medical cannabis company, currently conducting research with the aim of developing medical cannabis products for New Zealand. Prior to this she has held a number of senior pharmacy roles including independent consulting and Chief Pharmacist of Taranaki DHB for nearly 20 years. She was the President of the NZ Pharmaceutical Society for 5 years (2008-2013) and a ministerial appointment to the NHITB (National Health IT Board) for 8 years (2008-2016). She was a founding and active member of all the New Zealand medication safety committees over the past 20 years and a member of the original PHARMAC Hospital Procurement Advisory Committee (HPAC) serving for 3 years.

She has operated at the highest level in developing national government policy as well as at operational, clinical, technical and governance level. She is a registered pharmacist with fellowships awarded from the Pharmaceutical Society and College of Pharmacists. She has an Advanced Clinical Pharmacy Post Graduate Diploma and a Masters in Health Sciences, both with distinction. She is a trained Quality Health Auditor and very experienced in implementing electronic medication systems with the associated clinical change management.

Chris James is the Group Manager of Medsafe, the medicine and medical device regulator in New Zealand.

Chris is a registered pharmacist with over ten years’ experience in clinical pharmacy, including paediatric and neonatal pharmacy. In 2006 Chris joined Medsafe, initially in the pharmaceutical chemistry assessment of new medicines, then moving to the post market pharmacovigilance team.

Chris has experience in risk communication including developing the early warning and alert system to provide information about new and emerging safety issues.

Chris was appointed Manager of the Clinical Risk team in 2011, responsible for pharmacovigilance, providing clinical advice, risk communication, and the regulation of clinical trials. Chris is also leading the work to develop a medicinal cannabis regulatory scheme and has been Medsafe Group Manager since 2015.

Proudly Sponsored By:

Eqalis Research Limited, PO Box 99, Katikati


Course Information:

On completion of this course, pharmacists will be able to:

  • Describe the components of cannabis and the pharmacokinetics
  • Identify the difference between THC and CBD and how they react with the endocannabinoid receptors
  • Describe the dosing regimen for THC and CBD, include initiating doses and maximum daily doses
  • Explain cannabinoid treatment related tolerance, adverse effects and management
  • Identify Cannabinoid metabolism pathway and monitoring
  • Evaluate evidence-based medical cannabis treatment
  • Describe how human genetic variation can influence a person’s response to medical cannabis
  • Develop an understanding of the Misuse of Drugs (Medicinal Cannabis) Regulations 2019 and how these apply to pharmacy practice
  • Explain the application of regulations for unapproved medicines to medicinal cannabis products and products available from 1 April 2020

Competence Standards Assessed - M1.2, M1.3, M1.6, O1.4, O1.5


Accreditation number: C20/05 (expiry 17/03/2022) - This course has been accredited by PSNZ ENHANCE for 2 hours of group 2 learning and pharmacists may allocate 4 group two points on successful completion of the learning activity, evidenced by receipt of the PSNZ College Certificate of achievement.

Pharmacists must achieve a 80% pass mark in order to complete the course.

One learning package must be purchased for each individual to complete the course.

Non Member Registration

Non PSNZ members can register for this event. Please note you will need to register as a user on the PSNZ website before you can register to attend the event. Look for the "New user? Register now" option at the bottom of the Login screen.

Cancellation and Refund Policy:

Payment must be received before your access to the On Demand course will be made available to you.

Registrations are subject to our terms of trade and privacy policy. By submitting this application you agree to these terms and conditions.


By enrolling in this training, you are confirming that all work undertaken within this training course and assessment answers are your own. If there are grounds to believe that cheating or plagiarism has occurred, we will investigate and your work may be disallowed and you will be unable to complete the training.